The mRNA stability factor HuR inhibits MicroRNA-16 targeting of COX-2

Molecular Cancer Research

Volumn 10, Issue 1, 2012, Pages 167-180

  Young, Lisa E ^a   Moore, Ashleigh E ^a   Sokol, Lena ^b   Meisner Kober, Nicole ^b   Dixon, Dan A ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HUR PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 16; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER CELL; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA STABILITY;

ANIMALS; CACO-2 CELLS; CARCINOMA; CELLS, CULTURED; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HT29 CELLS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; MICE; MICE, TRANSGENIC; MICRORNAS; PROTEIN BINDING; PROTEIN TRANSPORT; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA STABILITY; TUMOR CELLS, CULTURED;

EID: 84856008627     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-11-0337     Document Type: Article

References (48)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
2. Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138:2101-14 e5.
3. Garneau NL, Wilusz J, Wilusz CJ. The highways and byways of mRNA decay. Nat Rev Mol Cell Biol 2007;8:113-26. (Pubitemid 46432531)
4. Anant S, Houchen CW, Pawar V, Ramalingam S. Role of RNA-binding proteins in colorectal carcinogenesis. Curr Colorectal Cancer Rep 2010;6:68-73.
5. Barreau C, Paillard L, Osborne HB. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 2005;33:7138-50. (Pubitemid 43125082)
6. Dixon DA, Tolley ND, King PH, Nabors LB, McIntyre TM, Zimmerman GA, et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 2001;108:1657-65. (Pubitemid 33144876)
7. Lopez de Silanes I, Fan J, Yang X, Zonderman AB, Potapova O, Pizer ES, et al. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 2003;22:7146-54. (Pubitemid 37378547)
8. Benjamin D, Moroni C. mRNA stability and cancer: an emerging link? Expert Opin Biol Ther 2007;7:1515-29. (Pubitemid 47597140)
9. Wang D, Dubois RN. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2010;29:781-8.
10. Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem 2000;275:11750-7. (Pubitemid 30237739)
11. Young LE, Dixon DA. Posttranscriptional regulation of cyclooxygenase 2 expression in colorectal cancer. Curr Colorectal Cancer Rep 2010;6:60-7.
12. Young LE, Sanduja S, Bemis-Standoli K, Pena EA, Price RL, Dixon DA. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 2009;136:1669-79.
13. Abdelmohsen K, Gorospe M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdisciplinary Reviews: RNA 2010;1:214-29.
14. Keene J. Why is Hu where? Shuttling of early-response messenger RNA subsets. Proc Natl Acad Sci USA 1999;96:5-7. (Pubitemid 29036041)
15. Brennan CM, Steitz JA. HuR and mRNA stability. Cell Mol Life Sci 2001;58:266-77. (Pubitemid 32217358)
16. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010;79:351-79.
17. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006;125:1111-24. (Pubitemid 43866197)
18. Kim HH, Kuwano Y, Srikantan S, Lee EK, Martindale JL, Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev 2009;23:1743-8.
19. Glorian V, Maillot G, Poles S, Iacovoni JS, Favre G, Vagner S. HuR-dependent loading of miRNA RISC to the mRNA encoding the Rasrelated small GTPase RhoB controls its translation during UV-induced apoptosis. Cell Death Differ 2011;18:1692-701.
20. von Roretz C, Gallouzi IE. Decoding ARE-mediated decay: is micro-RNA part of the equation? J Cell Biol 2008;181:189-94.
21. Meisner NC, Filipowicz W. Properties of the regulatory RNA-binding protein HuR and its role in controlling miRNA repression. Adv Exp Med Biol 2010;700:106-23.
22. Meisner NC, Hintersteiner M, Mueller K, Bauer R, Seifert JM, Naegeli HU, et al. Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat Chem Biol 2007;3:508-15. (Pubitemid 47080371)
23. Dixon DA, Tolley ND, Bemis-Standoli K, Martinez ML, Weyrich AS, Morrow JD, et al. Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest 2006;116:2727-38. (Pubitemid 44511636)
24. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 2004;23:3092-102. (Pubitemid 39093603)
25. Meisner NC, Hackermuller J, Uhl V, Aszodi A, Jaritz M, Auer M. mRNA openers and closers: modulating AU-rich element-controlled mRNA stability by a molecular switch in mRNA secondary structure. Chembiochem 2004;5:1432-47. (Pubitemid 39371510)
26. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005;120:623-34. (Pubitemid 40343075)
27. Shanmugam N, Reddy MA, Natarajan R. Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products. J Biol Chem 2008;283:36221-33.
28. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005;102:13944-9. (Pubitemid 41377683)
29. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010;466:835-40.
30. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009;10:704-14.
31. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001;1:11-21. (Pubitemid 33741877)
32. Denkert C, Koch I, von Keyserlingk N, Noske A, Niesporek S, Dietel M, et al. Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol 2006;9:1261-9. (Pubitemid 44268197)
33. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 2006;1:e116.
34. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 2008;36:5391-404.
35. Gruber AR, Fallmann J, Kratochvill F, Kovarik P, Hofacker IL. AREsite: a database for the comprehensive investigation of AU-rich elements. Nucleic Acids Res 2010;39:D66-9.
36. Bakheet T, Williams BR, Khabar KS. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 2006;34:D111-4.
37. Lopez de Silanes I, Quesada MP, Esteller M. Aberrant regulation of messenger RNA 30-untranslated region in human cancer. Cell Oncol 2007;29:1-17. (Pubitemid 46535188)
38. Kanies CL, Smith JJ, Kis C, Schmidt C, Levy S, Khabar KS, et al. Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition. Mol Cancer Res 2008;6:1124-36.
39. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;9:102-14.
40. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, Bartel DP. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 2010;38:789-802.
41. Sawaoka H, Dixon DA, Oates JA, Boutaud O. Tristetrapolin binds to the 3′ untranslated region of cyclooxygenase-2 mRNA: A polyadenylation variant in a cancer cell line lacks the binding site. J Biol Chem 2003;278:13928-35. (Pubitemid 36799934)
42. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, et al. The colorectal microRNAome. Proc Natl Acad Sci U S A 2006;103:3687-92. (Pubitemid 43376616)
43. Ahmed FE, Jeffries CD, Vos PW, Flake G, Nuovo GJ, Sinar DR, et al. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics 2009;6:281-95.
44. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 2008;105:5166-71. (Pubitemid 351738528)
45. Staub E, Grone J, Mennerich D, Röpcke S, Klamann I, Hinzmann B, et al. A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer. Mol Cancer 2006;5:37.
46. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008;40:43-50.
47. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNAprocessing by p53. Nature 2009;460:529-33.
48. Meisner NC, Hintersteiner M, Seifert JM, Bauer R, Benoit RM, Widmer A, et al. Terminal adenosyl transferase activity of posttranscriptional regulator HuR revealed by confocal on-bead screening. J Mol Biol 2009;386:435-50.